Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

New Hope from Israel: Data Suggests Vaccines Will Empty COVID-19 Wards

Develop Vaccines for Future Pandemics and Variants of COVID-19
When it comes to mass vaccination efforts, of the first 1.82 million inoculated, only 0.07% contracted COVID-19.

According to the latest data published by the Israeli Health Ministry, out of 1.82 million Israelis inoculated by early February only 1,248, 0.07%, tested positive for COVID-19 by February 25. Hence, only one in 1,500 fully vaccinated Israelis tested positive. This latest data provides the strongest indication yet that mass vaccination will eventually empty the COVID-19 wards in hospitals around the world.

As of today, Israel’s hospitals are still stretched thin treating almost 1,100 hospitalized COVID-19 patients, but even in this regard, there is a silver lining, since the vast majority of patients are unvaccinated, indicating that as the country’s vaccination drive steams on, COVID-19 patient numbers are likely to drop significantly.

“This data indicates that in a theoretical situation where we have 100% vaccine coverage, we would only need a few dozen COVID-19 beds in the entire country, and only a handful for patients in serious condition,” said Prof. Eyal Leshem, Director of the Travel & Tropical Medicine Center at Sheba Medical Center. According to Prof. Leshem, the drastic reduction in ventilator use among Israel’s most vaccinated age group, those 70+, shows that serious coronavirus illness has become an almost entirely avoidable phenomenon: “It indicates that people who are not getting vaccinated are akin to people who drive without safety belts,” he stated.

Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More